Inari, Stryker

Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Key Takeaways Shares of Inari Medical surged Monday afternoon and again Tuesday morning as reports of an imminent acquisition by Stryker turned into reality.Stryker will acquire Inari in an all-cash deal for $80 per share,
Device maker Stryker strikes $4.9 billion deal for Inari Medical
By Anirban Sen NEW YORK (Reuters) -Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.
Stryker agrees to acquire Inari Medical for $4.9bn
Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of nearly $4.9bn. Inari is poised to enhance Stryker's footprint in the peripheral vascular sector, particularly in the venous thromboembolism (VTE) market.
Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an approximate value of $4.9 billion.
Stryker strikes $4.9B deal to buy Inari Medical
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.
Inari Medical soars on report of Stryker talks
Inari Medical's stock surged 6% amid reports of advanced acquisition talks with Stryker, potentially closing a deal this week.
Stryker to acquire Inari Medical for $4.9B
Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.
Stryker inks $4.9B deal for blood clot buster Inari Medical
After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening its pocketbook a bit wider to acquire Inari Medical, with it | Stryker said the addition of Inari’s devices for venous thromboembolism will complement its current neurovascular business.
Stryker Agrees to Buy Inari Medical for $80 Per Share (2)
Medical device maker Stryker Corp. agreed to purchase Inari Medical Inc. for about $4.9 billion to expand its offerings in the fast-growing area of treating blood clots in the legs and lungs.
Inari Medical downgraded to Neutral from Buy at BTIG
BTIG downgraded Inari Medical (NARI) to Neutral from Buy without a price target after Stryker (SYK) entered a definitive agreement to acquire
Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...